Quantcast

Granite State Times

Thursday, September 19, 2024

New Hampshire: Biologics companies were the least FDA inspected companies in New Hampshire in Q1

Webp 51tcce8qtq0gv3h0ttdr040fsao9

Kimberlee Trzeciak Deputy Commissioner for Policy, Legislation, and International Affairs of FDA | Official Website

Kimberlee Trzeciak Deputy Commissioner for Policy, Legislation, and International Affairs of FDA | Official Website

In the first quarter of 2024, one Biologics company received an FDA inspection in New Hampshire, according to the U.S. Food and Drug Administration (FDA).

This was the lowest number of inspections per type of company made by the FDA in New Hampshire, equalling 25% of all inspections in the first quarter of 2024.

The FDA routinely inspects facilities across the nation to determine if the workplaces and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly for businesses to consistently make smarter business decisions for the future.

The FDA is a government agency primarily responsible for monitoring the manufacturing and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.

FDA Inspections in New Hampshire During Q1
Project AreaNo Action IndicatedVoluntary Action IndicatedOfficial Action Indicated
Compliance: Devices1----
Foodborne Biological Hazards2----
Human Cellular, Tissue, and Gene Therapies--1--
Postmarket Assurance: Devices1----
Vaccines and Allergenic Products1----

ORGANIZATIONS IN THIS STORY

!RECEIVE ALERTS

The next time we write about any of these orgs, we’ll email you a link to the story. You may edit your settings or unsubscribe at any time.
Sign-up

MORE NEWS